New bowel cancer drug '100% effective' in 'unprecedented' trial
The immunotherapy drug, Jemperli, from GSK was given to 42 patients with locally advanced mismatch repair deficient (dMMR) rectal cancer - a form of bowel cancer The trial focused on patients with a certain type of cancer ( Image: Getty Images/ …